Assessment of Early Pregnancy MAB Completion
Assessing Completion of Medication Abortion for Very Early Pregnancies
University of Washington
400 participants
Mar 13, 2025
OBSERVATIONAL
Conditions
Summary
This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Eligibility
Inclusion Criteria4
- Pregnant person with early pregnancy ≤42 days
- Eligible and consented to a medication abortion
- Have access to receiving text messages and the internet
- Able to read and understand English
Exclusion Criteria1
- \- Privacy or safety concerns about filling out the surveys
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will take a high-sensitivity urine pregnancy test at home weekly for up to 4 weeks compared to the taking just one home urine pregnancy test at 4-5 weeks. Participants will also complete short weekly questionnaires on their pregnancy symptoms and follow-up care.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06893484